Late enhancement in cardiac amyloidosis: Correlation of MRI enhancement pattern with histopathological findings

Amyloid

Volumn 15, Issue 3, 2008, Pages 196-204

  Hosch, Waldemar ^a   Kristen, Arnt V ^a   Libicher, Martin ^a,b   Dengler, Thomas J ^a   Aulmann, Sebastian ^c   Heye, Tobias ^a   Schnabel, Philip A ^c   Schirmacher, Peter ^c   Katus, Hugo A ^a   Kauczor, Hans Ulrich ^a,d   Longerich, Thomas ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Institute of Pathology   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Amyloidosis; Histopathology; Late enhancement; Magnetic resonance imaging

Indexed keywords

AMYLOID; COLLAGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CELL VACUOLE; CLINICAL ARTICLE; CYTOPLASM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHORESIS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HEART AMYLOIDOSIS; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING AND DISPLAY; IMMUNOHISTOLOGY; LABORATORY TEST; LATE ENHANCEMENT; MALE; MORPHOLOGY; MUSCLE FIBRIL; PRIORITY JOURNAL;

AMYLOIDOSIS; CARDIOMYOPATHIES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 54249089766     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120802193233     Document Type: Article

References (28)

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
2. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005;1753:11-22.
3. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998;136:824-830.
4. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole Wilson PA, Hawkins PN, Pennell DJ. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193.
5. Perugini E, Rapezzi C, Piva T, Leone O, Reggiani LB, Riva L, Salvi F, Lovato L, Branzi A, Fattori R. Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343-349.
6. Hosch W, Bock M, Libicher M, Ley S, Hegenbart U, Dengler TJ, Katus HA, Kauczor HU, Kauffmann GW, Kristen AV. MR-Relaxometry of Myocardial Tissue: Significant Elevation of T1 and T2 Relaxation Times in Cardiac Amyloidosis. Invest Radiol 2007;42:636-642.
7. Celletti F, Fattori R, Napoli G, Leone O, Rocchi G, Bacchi-Reggiani L, Gavelli G. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999;83:798-801, A10.
8. Mueller PS, Edwards WD, Gertz MA. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 2000;109:181-188.
9. Strege RJ, Saeger W, Linke RP. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. Virchows Arch 1998;433:19-27.
10. Altland K, Benson MD, Costello CE, Ferlini A, Hazenberg BP, Hund E, Kristen AV, Linke RP, Merlini G, Salvi F, Saraiva MJ, Singer R, Skinner M, Winter P. Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 2007;28:2053-2064.
11. Declaration of Helsinki. Recommendations guiding doctors in clinical research. Adopted by the World Medical Association in 1964. Wiss Med J 1967;66:25-26.
12. Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004;232:653-668.
13. vanden Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006;186:1682-1685.
14. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 2004;109:1328-1334.
15. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92:1117-1125.
16. Lim RP, Srichai MB, Lee VS. Non-ischemic causes of delayed myocardial hyperenhancement on MRI. AJR Am J Roentgenol 2007;188:1675-1681.
17. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-2264.
18. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318-3326.
19. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003;361:1787-1789.
20. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
21. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
22. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
23. Weber KT, Sun Y, Campbell SE. Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 1995;16 (Suppl. N):12-18.
24. Alloni A, Pellegrini C, Ragni T, Goggi C, D'Armini AM, Rinaldi M, Vigano M. Heart transplantation in patients with amyloidosis: single-center experience. Transplant Proc 2004;36:643-644.
25. Maurer MS, Raina A, Hesdorffer C, Bijou R, Colombo P, Deng M, Drusin R, Haythe J, Horn E, Lee SH, Marboe C, Naka Y, Schulman L, Scully B, Shapiro P, Prager K, Radhakrishnan J, Restaino S, Mancini D. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation 2007;83:539-545.
26. Gillmore JD, Goodman HJ, Lachmann HJ, Offer M, Wechalekar AD, Joshi J, Pepys MB, Hawkins PN. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006;107:1227-1229.
27. Dubrey SW, Burke MM, Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: The United Kingdom experience. J Heart Lung Transplant 2004;23:1142-1153.
28. Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA, Bluemke DA. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 2006;26:795-810.